Leach Jacob Steven 4
4 · DEXCOM INC · Filed Jan 30, 2025
Insider Transaction Report
Form 4
DEXCOM INCDXCM
Leach Jacob Steven
DirectorPresident, CEO, and Director
Transactions
- Award
Common Stock
2025-01-28+7,107→ 271,278 total - Sale
Common Stock
2025-01-29$86.91/sh−2,634$228,932→ 268,644 total
Holdings
- 47,296(indirect: Family Holdings)
Common Stock
Footnotes (4)
- [F1]Represents performance stock units ("PSUs") granted to the reporting person on March 8, 2022 that vested on January 28, 2025.
- [F2]Included in this number are 51,972 unvested restricted stock units, 26,053 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 16,931 of which were granted on March 8, 2023 and shall vest through March 8, 2026, and 8,988 of which were granted on March 8, 2022 and shall vest through March 8, 2025.
- [F3]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of PSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F4]Shares are held by the Gregg Family Grandchildren's Trust UAD 12/30/2010, with respect to which the reporting person's spouse is a trustee.